Clinical Trial and Research Centre (CTRC) (with 20 beds) capable of conducting Phase I and Phase II clinical trials will be set up in CMHHK to facilitate and conduct clinical research on proprietary Chinese medicines (pCms) including development of new pCms and expanding new clinical indications from existing pCms. The CTRC shall be set up to conduct internationally recognised high standard clinical research and provide a scientific research platform for the development of Chinese Medicine including Chinese medicines (CMs), especially in the therapeutic application of CMs, promotion of the clinical development of pCMs, and enhancement of the position of Chinese medicine in the international market.